A phase 2 prospective study of bortezomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed iMCD
- Resource Type
- Short Communication
- Source
- In
Blood 25 May 2023 141(21):2654-2657 - Subject
Clinical Trials and Observations Lymphoid Neoplasia - Language
- ISSN
- 0006-4971